Literature DB >> 20628836

Lessons from coronary intravascular ultrasound on the importance of raising high-density lipoprotein cholesterol.

Stephen J Nicholls1, Kiyoko Uno, E Murat Tuzcu, Steven E Nissen.   

Abstract

Technological advances have enhanced our ability to visualize the entire extent of atherosclerosis within the artery wall. Intravascular ultrasound has enabled characterization of the impact of medical therapies on progression of coronary atherosclerosis. Despite use of established anti-atherosclerotic therapy, cardiovascular disease still remains the leading cause of morbidity and mortality. There is an ongoing need to develop new therapeutic strategies to achieve more effective reduction in cardiovascular risk. Raising high-density lipoprotein cholesterol continues to receive attention as a therapeutic strategy. The relationship between high-density lipoprotein and progression of atherosclerosis and its implications for clinical practice are reviewed here.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628836     DOI: 10.1007/s11883-010-0125-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  61 in total

1.  Coronary plaque classification with intravascular ultrasound radiofrequency data analysis.

Authors:  Anuja Nair; Barry D Kuban; E Murat Tuzcu; Paul Schoenhagen; Steven E Nissen; D Geoffrey Vince
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

Review 2.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

Review 3.  Atherosclerosis imaging: intravascular ultrasound.

Authors:  E Murat Tuzcu; Paul Schoenhagen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

Authors:  W P James; A Astrup; N Finer; J Hilsted; P Kopelman; S Rössner; W H Saris; L F Van Gaal
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

5.  Effect of torcetrapib on the progression of coronary atherosclerosis.

Authors:  Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

6.  Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins.

Authors:  Allen J Taylor; Lance E Sullenberger; Hyun J Lee; Jeannie K Lee; Karen A Grace
Journal:  Circulation       Date:  2004-11-10       Impact factor: 29.690

7.  Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis.

Authors:  A M Dattilo; P M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

8.  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Authors:  Michiel L Bots; Frank L Visseren; Gregory W Evans; Ward A Riley; James H Revkin; Charles H Tegeler; Charles L Shear; William T Duggan; Ralph M Vicari; Diederick E Grobbee; John J Kastelein
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

9.  Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.

Authors:  Menno Vergeer; Michiel L Bots; Sander I van Leuven; Dick C Basart; Eric J Sijbrands; Gregory W Evans; Diederick E Grobbee; Frank L Visseren; Anton F Stalenhoef; Erik S Stroes; John J P Kastelein
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

10.  Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and women.

Authors:  Kulwara Meksawan; David R Pendergast; John J Leddy; Melanie Mason; Peter J Horvath; Atif B Awad
Journal:  J Am Coll Nutr       Date:  2004-04       Impact factor: 3.169

View more
  3 in total

Review 1.  Novel concepts in HDL pharmacology.

Authors:  Alan T Remaley; Giuseppe D Norata; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2014-06-20       Impact factor: 10.787

2.  Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.

Authors:  YongTae Kim; Francois Fay; David P Cormode; Brenda L Sanchez-Gaytan; Jun Tang; Elizabeth J Hennessy; Mingming Ma; Kathryn Moore; Omid C Farokhzad; Edward Allen Fisher; Willem J M Mulder; Robert Langer; Zahi A Fayad
Journal:  ACS Nano       Date:  2013-10-03       Impact factor: 15.881

3.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.